Pine Pharmaceuticals Llc
CAGE Code: 7JZE9
NCAGE Code: 7JZE9
Status: Active
Type: Commercial Supplier
Summary
Pine Pharmaceuticals Llc is an Active Commercial Supplier with the Cage Code 7JZE9.
Address
355 Riverwalk Pkwy
Tonawanda NY 14150-5837
United States
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
Technology Distribution Network Inc Goldsmith T R And Son Inc Winters Thermogauges Inc Cornerstone Direct Corp Timewise Div Cornerstone Direct Corp Csk Technical Inc Ashland Chemical Inc Union Carbide Corp Linde Div Wsf Industries Inc S R Instruments, Inc. Nowak A J Co Inc Northtowne Services Corp Turnkey Cornerstone Direct Ronco Power Systems Sure Flow Equipment Inc Sfc Adams, Inc. Conncor Inc Tonawanda Limb & Brace, Inc Pride Machine And Tool Co Inc Guildcraft Arts And Crafts
Frequently Asked Questions (FAQ) for CAGE 7JZE9
- What is CAGE Code 7JZE9?
- 7JZE9 is the unique identifier used by NATO Organizations to reference the physical entity known as Pine Pharmaceuticals Llc located at 355 Riverwalk Pkwy, Tonawanda NY 14150-5837, United States.
- Who is CAGE Code 7JZE9?
- 7JZE9 refers to Pine Pharmaceuticals Llc located at 355 Riverwalk Pkwy, Tonawanda NY 14150-5837, United States.
- Where is CAGE Code 7JZE9 Located?
- CAGE Code 7JZE9 is located in Tonawanda, NY, USA.
Contracting History for CAGE 7JZE9 Most Recent 25 Records
- 75N94023P00460
- The Purpose Of This Acquisition Is To Procure A Pine Pharmaceutical Intravenous Stable Isotope.
- 28 Jun 2023
- The Purpose Of This Acquisition Is To Procure A Pine Pharmaceutical Intravenous Stable Isotope.
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $230,422.80
- Department Of Health And Human Services (Hhs)
- 75N94023P00460
- The Purpose Of This Acquisition Is To Procure A Pine Pharmaceutical Intravenous Stable Isotope.
- 17 Aug 2023
- The Purpose Of This Acquisition Is To Procure A Pine Pharmaceutical Intravenous Stable Isotope.
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $230,422.80
- Department Of Health And Human Services (Hhs)
- 75N95022P00016
- Compounding Of 10% Polysorbate-80 To Dilute Tpm-001 Investigational Drug For Treatment Of Peritoneal Cancer
- 14 Dec 2021
- Compounding Of 10% Polysorbate-80 To Dilute Tpm-001 Investigational Drug For Treatment Of Peritoneal Cancer
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $26,556.52
- Department Of Health And Human Services (Hhs)
- 75N95022P00016
- Compounding Of 10% Polysorbate-80 To Dilute Tpm-001 Investigational Drug For Treatment Of Peritoneal Cancer
- 12 Sep 2023
- Compounding Of 10% Polysorbate-80 To Dilute Tpm-001 Investigational Drug For Treatment Of Peritoneal Cancer
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $23,753.53
- Department Of Health And Human Services (Hhs)
- 75N95022P00016
- Compounding Of 10% Polysorbate-80 To Dilute Tpm-001 Investigational Drug For Treatment Of Peritoneal Cancer
- 20 Sep 2022
- Compounding Of 10% Polysorbate-80 To Dilute Tpm-001 Investigational Drug For Treatment Of Peritoneal Cancer
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $23,753.53
- Department Of Health And Human Services (Hhs)
- 75N94023P00062
- Niddk - Acquisition Of Intravenous Stable Isotope
- 30 Nov 2022
- Niddk - Acquisition Of Intravenous Stable Isotope
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $12,580.80
- Department Of Health And Human Services (Hhs)
- 75N94023P00818
- Niddk - Acquisition Of An Intravenous Stable Isotope
- 14 Sep 2023
- Niddk - Acquisition Of An Intravenous Stable Isotope
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $22,303.20
- Department Of Health And Human Services (Hhs)
- 75N98022P00635
- Pine Pharmaceuticals, Llc:1270808 [22-000472]
- 27 Jan 2022
- Pine Pharmaceuticals, Llc:1270808 [22-000472]
- National Institutes Of Health Olao
- Department Of Health And Human Services (Hhs)
- $65,002.52
- Department Of Health And Human Services (Hhs)
- 75N95022P00607
- The Manufacture Of 4,000 Placebo Capsules For Patient Use, And 4,000 Over-Encapsulated Dutasteride 0.5Mg Gelatin Capsules For Patient Use For The Purpose Of A Double-Blind Study. Pine Pharmaceuticals, Llc:1270808 [22-005185]
- 8 Sep 2022
- The Manufacture Of 4,000 Placebo Capsules For Patient Use, And 4,000 Over-Encapsulated Dutasteride 0.5Mg Gelatin Capsules For Patient Use For The Purpose Of A Double-Blind Study. Pine Pharmaceuticals, Llc:1270808 [22-005185]
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $33,944.00
- Department Of Health And Human Services (Hhs)
- 75N94023P00207
- Niddk - Acquisition Of Intravenous Stable Isotope (D5 Glycerol, 6,6 D2-Glucose) For Metabolic Research
- 15 Feb 2023
- Niddk - Acquisition Of Intravenous Stable Isotope (D5 Glycerol, 6,6 D2-Glucose) For Metabolic Research
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $44,606.40
- Department Of Health And Human Services (Hhs)
- 75N94022P00285
- Niddk - 6,6 D2-Glucose 72.9 Mg/Ml (30 Ml) Vial
- 30 Mar 2022
- Niddk - 6,6 D2-Glucose 72.9 Mg/Ml (30 Ml) Vial
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $12,580.80
- Department Of Health And Human Services (Hhs)
- 75N98022P00635
- Pine Pharmaceuticals, Llc:1270808 [22-000472]
- 25 May 2022
- Pine Pharmaceuticals, Llc:1270808 [22-000472]
- National Institutes Of Health Olao
- Department Of Health And Human Services (Hhs)
- $116,700.00
- Department Of Health And Human Services (Hhs)
- 75N94023P00093
- Intravenous Stable Isotopes (6,6-D2 Glucose) For Metabolic Research [23-000014]
- 20 Dec 2022
- Intravenous Stable Isotopes (6,6-D2 Glucose) For Metabolic Research [23-000014]
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $139,191.00
- Department Of Health And Human Services (Hhs)